Edition:
United States

People: Anika Therapeutics Inc (ANIK.OQ)

ANIK.OQ on NASDAQ Stock Exchange Global Select Market

30.23USD
14 Dec 2018
Change (% chg)

$-0.95 (-3.05%)
Prev Close
$31.18
Open
$31.09
Day's High
$31.72
Day's Low
$30.14
Volume
30,691
Avg. Vol
32,145
52-wk High
$68.57
52-wk Low
$28.54

Cheung, Sylvia 

Ms. Sylvia Cheung is Chief Financial Officer, Treasurer, Secretary of Anika Therapeutics, Inc. Ms. Cheung served as our Vice President of Strategic Processes commencing in 2012. Since October 2014, she has also served as General Manager for our Italy-based subsidiary, Anika Therapeutics S.r.l., and she served in the same role from 2010 to 2011. Ms. Cheung originally joined our company as its Controller in 2005, and, in addition to fulfilling these financial responsibilities, she led our integration of Anika S.r.l. subsequent to its acquisition in 2009. Prior to joining Anika, she held a series of progressively responsible financial management positions at Transkaryotic Therapies, Inc. From 1995 to 2000, Ms. Cheung worked for PricewaterhouseCoopers LLP as an Audit Senior Associate with a focus in technology companies. Ms. Cheung holds a B.S. in business administration and accounting from the University of Massachusetts in Amherst and an M.B.A. from Boston University, and she is a Certified Public Accountant (inactive).

Basic Compensation

Total Annual Compensation, USD 544,912
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 727,774
Fiscal Year Total, USD 1,272,690

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joseph Darling

1,782,210

Sylvia Cheung

1,272,690

Thomas Finnerty

--

Edward Ahn

1,090,660

Richard Hague

1,055,150

Joseph Bower

188,959
As Of  30 Dec 2017